全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Hermansky-Pudlak Syndrome: A Case Report

DOI: 10.1155/2014/249195

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objective. The aim of this paper is to report the case of a patient diagnosed with Hermansky-Pudlak syndrome, as a result of bleeding diathesis. Clinical Presentation and Intervention. A 23-year-old male presented with recurrent epistaxis and, upon physical examination, was found to be remarkable for albinism and suborbital ecchymosis. The absence of dense bodies in the platelets was demonstrated using electron microscopy. This patient was (slowly) administered one unit of a platelet suspension, and his bleeding decreased considerably. Conclusion. This case shows that Hermansky-Pudlak syndrome should be considered in the differential diagnosis of a patient presenting with bleeding diathesis, when the clinical presentation also includes oculocutaneous albinism and visual problems. 1. Introduction Hermansky-Pudlak syndrome (HPS) is a hereditary multisystem disorder, characterized by oculocutaneous albinism and platelet storage deficiency, in which prolonged bleeding, pulmonary fibrosis, and granulomatous colitis may also occur. Although the first patients with this disorder were reported from Czechoslovakia, most of the subsequent patients have come from Puerto Rico [1]. There are nine types of human HPS reported to date, based on the genetic mutation from which the disorder stems [2]. Mutations observed in HPS are known to cause impairment of specialized secretory cells, including melanocytes, platelets, and lung alveolar type II epithelial cells. These patients demonstrate prolonged bleeding after surgical procedures and easy bruising [1]. The bleeding diathesis is variable; however, death from haemorrhaging has been reported [3]. Oculocutaneous albinism, the impairment of specialized secretory lysosomes in the melanocytes, is associated with HPS. The diagnosis is made by clinical findings of hypopigmentation of the skin and hair, eye characteristics, and the demonstration of absent dense bodies in the whole-mount electron microscopy of the platelets. The disease can cause dysfunction in the lungs, intestine, kidneys, or heart [1]. In this study, we report a case of HPS diagnosed as a result of bleeding diathesis. 2. Case Report A 23-year-old Turkish male with no significant disease history (with the exception of visual problems) presented with recurrent epistaxis after septoplasty operation. His past medical history indicated that he had bleeding episodes that were difficult to stop after circumcision and an appendectomy. He had no history of recurrent infections. His parents were unrelated, and he had one unaffected brother and sister. The physical

References

[1]  D. M. Pierson, D. Ionescu, G. Qing et al., “Pulmonary fibrosis in Hermansky—Pudlak syndrome: a case report and review,” Respiration, vol. 73, no. 3, pp. 382–395, 2006.
[2]  A. R. Cullinane, J. A. Curry, C. Carmona-Rivera et al., “A BLOC-1 mutation screen reveals that PLDN is mutated in Hermansky—Pudlak syndrome type 9,” American Journal of Human Genetics, vol. 88, no. 6, pp. 778–787, 2011.
[3]  B. H. Davies and E. G. Tuddenham, “Familial pulmonary fibrosis associated with oculocutaneous albinism and platelet function defect: a new syndrome,” Quarterly Journal of Medicine, vol. 45, no. 178, pp. 219–232, 1976.
[4]  C. Harrison, K. Khair, B. Baxter, I. Russell-Eggitt, I. Hann, and R. Liesner, “Hermansky—Pudlak syndrome: infrequent bleeding and first report of Turkish and Pakistani kindreds,” Archives of Disease in Childhood, vol. 86, no. 4, pp. 297–301, 2002.
[5]  J. G. White, “Electron-dense chains and clusters in platelets from patients with storage pool-deficiency disorders,” Journal of Thrombosis and Haemostasis, vol. 1, no. 1, pp. 74–79, 2003.
[6]  E. Maurer-Spurej, K. Dyker, W. Gahl, and D. V. Devine, “A novel immunocytochemical assay for the detection of serotonin in platelets,” British Journal of Haematology, vol. 116, no. 3, pp. 604–611, 2002.
[7]  P. H. Bolton-Maggs, E. A. Chalmers, P. W. Collins et al., “A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO,” British Journal of Haematology, vol. 135, no. 5, pp. 603–633, 2006.
[8]  U. Seligsohn, “Treatment of inherited platelet disorders,” Haemophilia, vol. 18, supplement 4, pp. 161–1155, 2012.
[9]  G. S. Dhaunsi, “Molecular mechanisms of organelle biogenesis and related metabolic diseases,” Medical Principles and Practice, vol. 14, no. 1, pp. 49–57, 2005.
[10]  P. W. Wijermans and D. B. van Dorp, “Hermansky—Pudlak syndrome: correction of bleeding time by 1-desamino-8D-arginine vasopressin,” American Journal of Hematology, vol. 30, no. 3, pp. 154–157, 1989.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413